First bionic eye developed: restores sight by bypassing damaged optic nerves

The Gennaris Bionic Vision System is the first bionic eye designed to restore visual perception by bypassing damaged optic nerves and transmitting signals directly to the brain’s visual center

The treatment of blindness is experiencing a real revolution thanks to “Gennaris Bionic Vision System”, the first bionic eye developed by researchers at Monash University in Australia. This cutting-edge technology represents a major breakthrough in medicine, offering new hope to millions of blind people.

The system was designed to restore visual perception by bypassing damaged optic nerves and transmitting signals directly to the visual center of the brain. The heart of the Gennaris Bionic Vision System is a complex system composed of a miniature camera which the user wears on a specially designed headgear, and a series of wireless implants.

The camera captures high resolution images that come processed by a vision unit. The processed data is then sent to implants surgically inserted into the primary visual cortex of the brain. Each implant, about the size of a fingernail, contains microelectrodes and advanced circuits capable of stimulating brain cells via electrical impulses, translating the signals into visual perceptions.

Allows 100 degree vision

One of the distinctive features of the Gennaris system is the ability to offer a wider and more natural field of vision compared to previous technologies. Currently the device allows one 100 degree visionsignificantly overcoming the limitations of past solutions that stopped at 70 degrees.

This was possible thanks to innovations such as the use of highly reactive nanowires, which improve the speed of image processing. Although the visual range, represents a significant improvement over previous attempts.

The Gennaris Bionic Vision System is the result of almost ten years of research. Preclinical tests conducted on animals, such as sheep, have demonstrated the effectiveness and safety of the systempaving the way for the first human clinical trials in Melbourne. During these trials the team of researchers will further evaluate the potential of the technology to provide a concrete improvement in the quality of life of those suffering from incurable blindness.

This extraordinary innovation, born from the collaboration between science and technology, has the potential to radically transform the treatment of blindness, restoring autonomy and hope to those who need it most. As clinical trials progress, the Gennaris Bionic Vision System may soon become an accessible reality, marking a new era for medicine.